Predictive marker for EGFR inhibitor treatment

Details for Australian Patent Application No. 2008286335 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Klughammer, Barbara; Delmar, Paul; Lutz, Verena; McLoughlin, Patricia

Agent Davies Collison Cave

Pub. Number AU-B-2008286335

PCT Pub. Number WO2009/021682

Priority 07114309.3 14.08.07 EP

Filing date 7 August 2008

Wipo publication date 19 February 2009

Acceptance publication date 27 October 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/021682 Priority application(s): WO2009/021682

27 October 2011 Application Accepted

  Published as AU-B-2008286335

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008286336-Predictive marker for EGFR inhibitor treatment

2008286334-EGFR inhibitor treatment marker